Consumer Information for: APRI 28
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
- to prevent pregnancy.
What it does
APRI®
is a combination hormonal contraceptive because it
contains two female sex hormones (desogestrel and ethinyl
estradiol). It is in the form of a tablet, therefore it is
known as a birth control pill or oral contraceptive. It has
been shown to be highly effective in preventing pregnancy
when taken as prescribed by your doctor. Pregnancy is
always more risky than taking birth control pills, except in
smokers over 35.
Combination hormonal contraceptives work in two ways:
- They inhibit the monthly release of an egg by the ovaries.
- They change the mucus produced by the cervix. This slows the movement of the sperm through the mucus and through the uterus (womb).
Effectiveness of Birth Control Pills
Combination birth control pills are more than 99 percent effective in preventing pregnancy when:
- the pill is TAKEN AS DIRECTED, and
- the amount of estrogen is 20 micrograms or more
A 99 percent effectiveness rate means that if 100 women used
birth control pills for one year, one woman in the group would
get pregnant.
The chance of becoming pregnant increases with incorrect use.
Other Ways to Prevent Pregnancy
Other methods of birth control are available to you. They are
usually less effective than birth control pills. When used
properly, however, other methods of birth control are effective
enough for many women.
The following table gives reported pregnancy rates for various forms of birth control, including no
birth control.
The reported rates represent the number of women out of
100 who would become pregnant in one year.
Reported Pregnancies per 100 Women per Year:
Combination pill | less than 1 to 2 |
Intrauterine device (IUD) | less than 1 to 6 |
Condom with spermicidal foam or gel | 1 to 6 |
Mini-pill | 3 to 6 |
Condom | 2 to 12 |
Diaphragm with spermicidal foam or gel | 3 to 18 |
Spermicide | 3 to 21 |
Sponge with spermicide | 3 to 28 |
Cervical cap with spermicide | 5 to 18 |
Periodic abstinence (rhythm), all types | 2 to 20 |
No birth control | 60 to 85 |
Pregnancy rates vary widely because people differ in how
carefully and regularly they use each method. (This does
not apply to IUDs since they are implanted in the uterus.)
Regular users may achieve pregnancy rates in the lower
ranges. Others may expect pregnancy rates more in the
middle ranges.
The effective use of birth control methods other than birth
control pills and IUDs requires more effort than taking
a single pill every day. It is an effort that many couples
undertake successfully.
When it should not be used
Combination hormonal contraceptives are not suitable for
every woman. In a small number of women, serious side
effects may occur. Your doctor can advise you if you have
any conditions that would pose a risk to you. The use of
the birth control pill always should be supervised by your
doctor.
You should not use APRI®
if you have or have had any of the
following conditions:
- blood clot in the legs, lungs, eyes or elsewhere, or thrombophlebitis(inflammation of the veins)
- stroke, heart attack or coronary artery disease (e.g. Angina pectoris) or a condition that may be a first sign of stroke (such as transient ischemic attack or small reversible stroke)
- disease of the heart valves with complications
- severe high blood pressure
- diabetes with complications
- known abnormalities of the blood clotting system that increases your risk for developing blood clots
- very high blood cholesterol or triglyceride levels
- you smoke
- migraine headaches
- you are scheduled for major surgery
- prolonged bed rest
- jaundice (yellowing of the eyes or skin), severe liver disease and your liver is not yet working normally
- Hepatitis C and are taking the combination drug regimen ombitasvir/paritaprevir/ritonavir, with or without dasabuvir (see “INTERACTIONS WITH THIS MEDICATION”).
- liver tumor(s)
- known suspected cancer of the breast or uterus (womb) or other estrogen-dependent cancer
- unusual vaginal bleeding without a known reason
- loss of vision due to blood vessel disease of the eye
- you are pregnant or suspect you may be pregnant
- pancreatitis (inflammation of the pancreas) associated with high levels of fatty substance in your blood
- allergy (hypersensitivity) to ethinyl estradiol, desogestrel, or to any of the other ingredients in APRI® (see What the medicinal ingredients are and What the non-medicinal ingredients are).
What the medicinal ingredient is
desogestrel and ethinyl estradiol.
What the non-medicinal ingredients are
Inactive ingredients include Lactose monohydrate;
Pregelatinized starch; Vitamin E; Povidone; Colloidal
silicon dioxide; Stearic acid; Opadry Maroon YS-1-16002
containing: hydroxypropyl methylcellulose, titanium
dioxide, polyethylene glycol. FD&C red no. 40 aluminum
lake, polysorbate 80, FD&C blue no. 2 aluminum lake;
Opadry Clear YS-1-7472 containing: hydroypropyl
methylcellulose and polyethylene glycol.
APRI 28 also contains the following inactive ingredients:
Anhydrous lactose; Pregelatinized starch; Microcrystalline
cellulose; Magnesium Stearate.
What dosage form it comes in
APRI® 21: Each sachet contains an Aclar blister dispenser
with 21 round rose active tablets. Each rose colored tablet
(debossed with “dp” on one side and “575” on the other side)
contains 0.15 mg desogestrel and 0.03 mg ethinyl estradiol.
APRI® 28: Each sachet contains an Aclar blister dispenser
with 21 round rose active tablets and 7 round white inert
tablets. Each rose colored tablet (debossed with “dp” on one
side and “575” on the other side) contains 0.15 mg desogestrel
and 0.03 mg ethinyl estradiol. Each white tablet (debossed with
“dp” on one side and “570” on the other side) contains inert
ingredients.
Warnings and precautions
Serious Warnings and Precautions
Cigarette smoking increases the risk of serious adverse
effects on the heart and blood vessels. This risk
increases with age and becomes significant in hormonal
contraceptive users older than 35 years of age and with
the number of cigarettes smoked. For this reason,
combination oral contraceptives, including APRI®
should not be used by women who are over 35 years of
age and smoke.
Combination hormonal contraceptives DO NOT
PROTECT against sexually transmitted infections
(STIs), including HIV/AIDS. For protection against
STIs, it is advisable to use latex condoms IN
COMBINATION WITH birth control pills.
BEFORE you use APRI® talk to your doctor or pharmacist if you:
- smoke
- are overweight
- have a history of breast disease (e.g., breast lumps) or a family history of breast cancer
- have high blood pressure
- have high cholesterol
- have diabetes
- have heart or kidney disease
- have a history of seizures/epilepsy
- have a history of depression
- have a history of liver disease or jaundice
- wear contact lenses
- have uterine fibroids (benign tumours of the uterus)
- may be pregnant or are breast feeding
- have systemic lupus erythematosus
- have inflammatory bowel disease such as Crohn’s disease or ulcerative colitis
- have haemolytic uremic syndrome
- have sickle cell disease
- have problems with the valves in your heart and/or have an irregular heart rhythm,
- have been told that you have a condition called hereditary angioedema or if you have had episodes of swelling in body parts such as hands, feet, face or airway passages
- have recently given birth
You should also inform your doctor about a family history
of blood clots, heart attacks and strokes.
If you see a different doctor, inform him or her that you are using APRI®
.
Tell your doctor if you are scheduled for any laboratory tests
since certain blood tests may be affected by hormonal
contraceptives.
Also tell your doctor if you are scheduled for MAJOR
surgery or if your ability to move around is limited for a
long period of time. You should consult your doctor about
stopping the use of APRI®
four weeks before surgery and
not using APRI® for a time period after surgery or during
bed rest.
APRI®
should be used only under the supervision of a
doctor, with regular follow-up to identify side effects
associated with its use. Your visits may include a blood
pressure check, a breast exam and a pelvic exam, including a
Pap smear. Visit your doctor three months or sooner
after the initial examination. Afterward, visit your doctor at
least once a year. Use APRI®
only on the advice of your
doctor and carefully follow all directions given to you. You
must use the birth control pill exactly as prescribed.
Otherwise, you may become pregnant.
If you and your doctor decide that, for you, the benefits of APRI® outweigh the risks, you should be aware of the following:
THE RISKS OF USING COMBINATION HORMONAL CONTRACEPTIVES
- Circulatory disorders (including blood clot in legs, lungs, heart, eyes or brain)
Blood clots are the most common serious side effects of birth
control pills. The risk of developing clots is high during the
first year a woman uses a hormonal contraceptive. The risk
is also higher if you restart a hormonal contraceptive (the same
product or a different product) after a break of 4 weeks or
more. Clots may occur in many areas of the body.
Be alert for the following symptoms and signs of serious
adverse effects. Call your doctor immediately if they occur:
- Sharp pain in the chest, coughing blood, or sudden shortness of breath. These symptoms could indicate a possible blood clot in the lung.
- Pain and/or swelling in the calf. These symptoms could indicate a possible blood clot in the leg.
- Crushing chest pain or heaviness. These symptoms could indicate a possible heart attack.
- Sudden severe or worsening headache or vomiting, dizziness or fainting, disturbance of vision or speech, or weakness or numbness in an arm or leg. These symptoms could indicate a possible stroke.
- Sudden partial or complete loss of vision. This symptom could indicate a possible blood clot in the eye.
Any of these conditions can cause death or disability. Clots
also occur rarely in the blood vessels of the eye, resulting in
blindness or impaired vision or in a blood vessel leading to an
arm or leg, resulting in damage to or loss of a limb.
Women who use hormonal contraceptives have a higher risk
of developing blood clots, but not as high as the risk during
pregnancy. The risk of clotting seems to increase with higher
estrogen doses. It is important, therefore, to use as low a
dosage of estrogen as possible.
The most significant risk factors for breast cancer are
increasing age and a strong history of breast cancer in the
family (mother or sister). Other established risk factors include
obesity, never having children, and having your first full-term
pregnancy at a late age.
Some women who use birth control pills may be at increased
risk of developing breast cancer before menopause, which
occurs around age 50. These women may be long-term users
of birth control pills (more than eight years) or women who
start using birth control pills at an early age.
In a few women, the use of birth control pills may accelerate
the growth of an existing but undiagnosed breast cancer. Early
diagnosis, however, can reduce the effect of breast cancer on
a woman’s life expectancy. The potential risks related to birth
control pills seem to be small, however; a yearly breast
examination is recommended for all women.
ASK YOUR DOCTOR FOR ADVICE AND
INSTRUCTIONS OF REGULAR SELF- EXAMINATION
OF YOUR BREASTS.
Some studies have found an increase of cancer of the cervix
in women who use hormonal contraceptives, although this
finding may be related to factors other than the use of oral
contraceptives. However, there is insufficient evidence to
rule out the possibility that oral contraceptives may cause
such cancers.
Chronic infection with the Human Papilloma Virus (HPV) is
believed to be the most important risk factor for cervical
cancer. In women who use combination oral contraceptives
(COCs) for a long time the chance of getting cervical cancer
may be slightly higher. This finding may not be caused by
the Pill itself but may be related to sexual behavior and other
factors.
The short and long-term use of birth control pills also has been linked with the growth of liver tumors or liver injury (e.g., hepatitis, hepatic function abnormal). Such tumors are extremely rare.
Contact your doctor immediately if you experience nausea, vomiting, severe pain or a lump in the abdomen.
Users of hormonal contraceptives have a greater risk of developing gallbladder disease requiring surgery within the first year of use. The risk may double after four or five years of use.
Birth control pills should not be taken by pregnant women. They will not prevent the pregnancy from continuing. There is no evidence, however, that the birth control pill can damage a developing child. You should check with your doctor about risks to your unborn child from any medication taken during pregnancy.
You will be at increased risk for blood clots. Your doctor will advise you of the appropriate time to start the use of APRI® after childbirth, miscarriage or therapeutic abortion.
You will have a menstrual period when you stop using APRI® . You should delay pregnancy until another menstrual period occurs within four to six weeks. In this way, the pregnancy can be more accurately dated. Contact your doctor for recommendations on alternate methods of contraception during this time.
If you are breast-feeding, consult your doctor before starting the birth control pill. Adverse effects on the child have been reported, including yellowing of the skin (jaundice) and breast enlargement. You should use another method of contraception. The use of oral contraceptives is generally not recommended until the nursing mother has completely weaned her child.
Interactions with this medication
Certain drugs may interact with combination hormonal contraceptives and prevent them from working properly making them less effective in preventing pregnancy or causing unexpected bleeding (spotting or breakthrough bleeding). Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines or herbal products, even those without a prescription. Also tell any other doctor or dentist (or the dispensing pharmacist) who prescribes another medicine that you use APRI®.
Drugs that may interact with APRI® include:
- drugs used for the treatment of epilepsy (e.g., primidone, phenytoin, barbiturates (e.g. phenobarbital, carbamazepine, oxcarbazepine, topiramate, felbamate)
- drugs used for the treatment of tuberculosis (e.g., rifampicin, rifabutin)
- drugs used for the treatment of HIV infections or AIDS (e.g., ritonavir, nelfinavir, nevirapine, efavirenz) and Hepatitis C Virus (e.g. boceprevir, telaprevir)
- antibiotics (e.g., nitrofurantoin) for infectious diseases
- antifungals (e.g. griseofulvin)
- cholesterol lowering agents (e.g. clofibrate)
- anti-coagulants(blood thinners)
- the herbal remedy St. John’s wort
- antihypertensive drugs (for high blood pressure)
- drugs used for high blood pressure in the blood vessels of the lungs (bosentan)
- antidiabetic drugs and insulin (for diabetes)
- prednisone
- sedatives and hypnotics (e.g. barbiturates, glutethimide, meprobamate)
- antidepressants(e.g. clomipramine)
- other drugs such as phenylbutazone, antihistamines, pain medications, anti-migraine preprations,
- some nutritional supplements (e.g. Vitamin E and Vitamin B12)
- cyclosporine
- Antacids (use 2 hours before or after taking APRI® )
If you are taking medicines or herbal products that might make APRI® less effective, a barrier contraceptive method should also be used. Since the effect of another medicine on APRI® may last up to 28 days after stopping the medicine, it is necessary to use the additional barrier contraceptive method for that long.
APRI® may also interfere with the working of other drugs, causing either an increase in effect (e.g., cyclosporin) or a decrease in effect (e.g., lamotrigine).
Do not use APRI® if you have Hepatitis C and are being treated with ombitasvir/paritaprevir/ritonavir, with or without dasabuvir. Using these drugs at the same time as APRI® may cause problems with your liver, such as an increase in the ALT liver enzyme. You can usually start APRI® about 2 weeks after finishing treatment with this combination of drugs used for Hepatitis C, but always consult with your doctor or pharmacist (See ABOUT THIS MEDICATION - When it should not be used”)
This is not a complete list of possible drug interactions with APRI® . Talk to your doctor for more information about drug interactions.
Proper use of this medication
Usual Dose
INFORMATION TO PATIENT ON HOW TO TAKE APRI® :
- READ THESE DIRECTIONS
- before you start taking your pills, and
- any time you are not sure what to do.
- 21-PILL PACK: 21 active pills (with hormones) taken daily for three weeks, and then take no pills for one week. or
- 28-PILL PACK: 21 active pills (with hormones) taken daily for three weeks, and then seven "reminder" pills (no hormones) taken daily for one week.
ALSO CHECK the pill pack for instructions on 1) where to start and 2) direction to take pills. In addition to this information leaflet, the 21 and 28 pill pack includes a card with Day of the Week Label Strips.
- when you start a pack late
- when you miss pills at the beginning or at the very end of the pack.
- ANOTHER KIND OF BIRTH CONTROL (such as latex condoms and spermicidal foam or gel) to use as a backup in case you miss pills, and
- AN EXTRA, FULL PACK OF PILLS.
- before you start taking your pills, and
- any time you are not sure what to do.
Decide with your doctor or clinic what is the best day for you to start taking your first pack of pills. Your pills may be either a 21-day or a 28-day type.
- APRI® 21-DAY COMBINATION
- THE FIRST DAY OF YOUR MENSTRUAL PERIOD (BLEEDING) IS DAY 1 OF YOUR CYCLE.
- Take one pill at approximately the same time every day for 21 days; THEN TAKE NO PILLS FOR SEVEN DAYS. Start a new pack on the eighth day. You will probably have a period during the seven days off the pill. (This bleeding may be lighter and shorter than your usual period.)
- APRI® 28-DAY COMBINATION
- THE FIRST DAY OF YOUR MENSTRUAL
PERIOD (BLEEDING) IS DAY 1 OF YOUR CYCLE.
Your doctor may advise you to start taking the pills on Day 1 or on the first Sunday after your period begins. If your period starts on Sunday, start that same day.
Select the appropriate day-of-the-week label strip. It starts with Day 1 of your menstrual period (for Day 1 starts) or Sunday (for Sunday starts). Apply it to the blister pack above the first row of tablets. This can help remind you to take your pill every day. - Take one pill at approximately the same time every day for 28 days. Begin a new pack the next day, NOT MISSING ANY DAYS ON THE PILLS. Your period should occur during the last seven days of using that pill pack.
- TAKE A PILL AT APPROXIMATELY THE SAME TIME EVERY DAY UNTIL THE PACK IS EMPTY.
With this type of birth control pill, you are 21 days on pills with seven days off pills. You must not be off the pills for more than seven days in a row.
Your doctor may advise you to start taking the pills on Day 1
or on the first Sunday after your period begins. If your
period starts on Sunday, start that same day.
Select the appropriate day-of-the-week label strip. It starts
with Day 1 of your menstrual period (for Day 1 starts) or
Sunday (for Sunday starts). Apply it to the blister pack above
the first row of tablets. This can help remind you to take your
pill every day.
With this type of birth control pill, you take 21 pills which contain hormones and seven pills which contain no hormones.
No preceding hormonal contraceptive use (in the past month)
Changing from a combined hormonal contraceptive
(combined oral contraceptive (COC), vaginal ring, or
transdermal patch)
The woman should start with APRI®
preferably on the day
after the last active tablet (the last tablet containing
the active substances) of her previous COC, but at the
latest on the day following the usual tablet-free interval or
following the last placebo tablet of her previous COC. In
case a vaginal ring or transdermal patch has been used, the
woman should start using APRI® preferably on the day of
removal, but at the latest when the next application would
have been due.
Changing from a progestogen-only-method (minipill,
injection, implant) or from a progestogen-releasing
intrauterine system (IUS)
The woman may switch any day from the minipill (from
an implant or the IUS on the day of its removal, from an
injectable when the next injection would be due), but should
in all of these cases be advised to additionally use a barrier
method for the first 7 days of tablet-taking.
Following first-trimester abortion
The woman may start immediately. When doing so, she need not take additional contraceptive
measures.
Following delivery or second-trimester abortion
For breastfeeding women see WARNINGS AND
PRECAUTIONS - Nursing Women.
Women should be advised to start at day 21 to 28 after
delivery or second trimester abortion. When starting later,
the woman should be advised to additionally use a barrier
method for the first 7 days of tablet-taking. However, if
intercourse has already occurred, pregnancy should be
excluded before the actual start of COC use or the woman
has to wait for her first menstrual period.
WHAT TO DO DURING THE MONTH
- Try to associate taking your pill with some regular activity like eating a meal or going to bed.
- Do not skip pills even if you have bleeding between monthly periods or feel sick to your stomach (nausea).
- Do not skip pills even if you do not have sex very often.
- 21 PILLS
WAIT SEVEN DAYS to start the next pack. You will have your period during that week. - 28 PILLS
Start the next pack ON THE NEXT DAY. Take one pill every day. Do not wait any days between packs.
Overdose
Overdosage may cause nausea, vomiting, breast tenderness, dizziness, abdominal pain and fatigue/drowsiness. Withdrawal bleeding may occur in females.
If you think you have taken too much APRI®, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.
Missed Dose
The following chart outlines the actions you should take if you miss one or more birth control pills. Match the number of pills missed with the appropriate starting time for the type of pill pack.
SUNDAY START | DAY 1 START |
---|---|
MISS 1 PILL | |
Take it as soon as you remember, and take the next pill at the usual time. This means that you might take 2 pills in one day. | Take it as soon as you remember, and take the next pill at the usual time. This means that you might take 2 pills in one day. |
MISS 2 PILLS IN A ROW | |
First 2 Weeks:
|
First 2 Weeks:
|
Third Week:
IF YOU MISS 2 PERIODS IN A ROW, CALL YOUR DOCTOR OR CLINIC. |
Third Week:
IF YOU MISS 2 PERIODS IN A ROW, CALL YOUR DOCTOR OR CLINIC. |
MISS 3 OR MORE PILLS IN A ROW | |
Anytime in the Cycle:
IF YOU MISS 2 PERIODS IN A ROW, CALL YOUR DOCTOR OR CLINIC. |
Anytime in the Cycle:
IF YOU MISS 2 PERIODS IN A ROW, CALL YOUR DOCTOR OR CLINIC. |
NOTE: 28-DAY PACK: If you forget any of the seven "reminder" pills (without hormones) in Week 4, just safely dispose of the pills you missed. Then keep taking one pill each day until the pack is empty. You do not need to use a back-up method.
Always be sure you have on hand:
- a back-up method of birth control (such as latex condoms and spermicidal foam or gel) in case you miss pills, and
- an extra, full pack of pills.
IF YOU FORGET MORE THAN ONE PILL TWO MONTHS IN A ROW, TALK TO YOUR DOCTOR OR CLINIC. Talk about ways to make pill-taking easier or about using another method of birth control.
Non-contraceptive benefits of Combined Hormonal
Contraceptives
Several health advantages have been linked to the use of
hormonal contraceptives.
- Reduction in the incidence of cancer of the uterus and ovaries
- Reduction in the likelihood of developing benign (noncancerous) breast disease and ovarian cysts.
- Less menstrual blood loss and more regular cycles. The risk of developing iron-deficiency anemia is thus reduced.
- There may be a decrease in painful menstruation and premenstrual syndrome (PMS).
- Acne, excessive hair growth and male-hormone- related disorders also may be improved.
- Ectopic (tubal) pregnancy may occur less frequently
- Acute pelvic inflammatory disease may occur less frequently.
Side effects and what to do about them
The following side effects have been observed in women taking Combination hormonal contraceptives in general, including APRI®:
- headache
- dysmenorrhea (painful menstrual cramps)
- abdominal (stomach) pain
- nausea
- upper respiratory tract infections (bronchitis, runny or stuffy nose, sore throat, etc.)
- back pain
- breast tenderness
- pharyngitis (sore throat)
- diarrhea
- vomiting
- asthenia (loss of strength, weakness, fatigue)
- malaise (feeling of physical discomfort or uneasiness)
- cough
- influenza (flu-like symptoms, fever)
- depression
- migraine, severe headaches
- dizziness
- dyspepsia (indigestion)
- vaginal irritation or infections
- cystitis (urinary tract infections or inflammation)
- amenorrhea (lack of a period or breakthrough bleeding, bleeding between menstrual periods)
- weight gain
- difficulty wearing contact lenses
- acne
- insomnia, nervousness
- allergy
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and call your doctor or Only if pharmacist |
---|---|---|---|
Uncommon | |||
sharp pain in the chest, coughing blood, or sudden shortness of breath/blood clot in the lung | ✔ | ||
Pain in the calf/blood clot in the leg | ✔ | ||
Crushing chest pain or heaviness/heart attack | ✔ | ||
Sudden severe or worsening headache or vomiting, dizziness or fainting, disturbance of vision or speech, or weakness or numbness in the arm or leg/stroke | ✔ | ||
Sudden partial or complete loss of vision or double vision/blood clot in the eye | ✔ | ||
abnormal liver test and/or nausea, vomiting, severe pain or lump in the abdomen/liver tumour | ✔ | ||
persistent sad mood | ✔ | ||
Yellowing of the skin/jaundice | ✔ | ||
Unusual swelling of the extremities | ✔ | ||
Breast lumps/breast cancer | ✔ | ||
unexpected (abnormal) vaginal bleeding | ✔ |
This is not a complete list of side effects. For any unexpected effects while taking APRI®, contact your doctor or pharmacist.
How to store
Store between 15-30°C. Keep in a safe place out of the reach and sight of children and pets.
Reporting side effects
Reporting Side Effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php ) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345
Note: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about APRI®:
- Talk to your healthcare professional
- Find the full Product Monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); the manufacturer’s website http://www.tevacanada.com; or by calling 1-800-268- 4127 ext. 3; or email druginfo@tevacanada.com.
This leaflet was prepared by Teva Canada Limited, Toronto, Ontario M1B 2K9
Last revised: November 27, 2020
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
CEFUROXIME FOR INJECTION, USP | 02422301 | HIKMA CANADA LIMITED | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G / VIAL |
CEFUROXIME FOR INJECTION, USP | 02422328 | HIKMA CANADA LIMITED | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G / VIAL |
CEFUROXIME FOR INJECTION, USP | 02422298 | HIKMA CANADA LIMITED | CEFUROXIME (CEFUROXIME SODIUM) 750 MG / VIAL |